Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Persistent Advanced Cervical Carcinoma”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Testing effectiveness (Phase 2)Study completedNCT04188860
What this trial is testing

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy

Who this might be right for
Recurrent Cervical CarcinomaPersistent Advanced Cervical CarcinomaChemotherapy+2 more
Lei Li 34
Testing effectiveness (Phase 2)Looking for participantsNCT07195734
What this trial is testing

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

Who this might be right for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Recurrent Head and Neck Squamous Cell Carcinoma+15 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)UnknownNCT04651127
What this trial is testing

Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer

Who this might be right for
Cervical CancerCervix CancerCervix Neoplasm
Sun Yat-sen University 40
Testing effectiveness (Phase 2)Study completedNCT00016926
What this trial is testing

Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group
Testing effectiveness (Phase 2)Study completedNCT06226350
What this trial is testing

A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma

Who this might be right for
Cervical Cancer
Shandong New Time Pharmaceutical Co., LTD 29
Early research (Phase 1)UnknownNCT05475847
What this trial is testing

Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Fudan University 20
Early research (Phase 1)Study completedNCT01281852
What this trial is testing

Paclitaxel, Cisplatin, and Veliparib in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+2 more
National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT00430781
What this trial is testing

Pazopanib Plus Lapatinib Compared to Lapatinib Alone and Pazopanib Alone In Subjects With Metastatic Cervical Cancer

Who this might be right for
Neoplasms, Uterine CervixMetastatic Cervical Cancer
GlaxoSmithKline 228
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)UnknownNCT05310383
What this trial is testing

Tislelizumab and Radiotherapy for Recurrent Cervical Cancer

Who this might be right for
Recurrent Cervical CarcinomaMetastatic Cervical CarcinomaPersistent Cervical Carcinoma+7 more
Lei Li 58
Large-scale testing (Phase 3)WithdrawnNCT02446652
What this trial is testing

Evaluation of TRANSKRIP ® Plus Chemotherapy in Recurrent-Persistent Cervical Cancer

Who this might be right for
Cervical Cancer
National Institute of Cancerología
Testing effectiveness (Phase 2)UnknownNCT05290935
What this trial is testing

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial

Who this might be right for
Recurrent Cervical CarcinomaPersistent Advanced Cervical CarcinomaChemotherapy+3 more
Lei Li 122
Not applicableUnknownNCT05310305
What this trial is testing

PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer

Who this might be right for
Immune Checkpoint InhibitorsAnti-programmed Death-1 AntibodyRadiotherapy+7 more
Lei Li 20
Testing effectiveness (Phase 2)Ended earlyNCT00138151
What this trial is testing

Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer

Who this might be right for
Cervical Cancer
University of Medicine and Dentistry of New Jersey 33
Post-approval studies (Phase 4)UnknownNCT00274885
What this trial is testing

Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer

Who this might be right for
Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 58
Testing effectiveness (Phase 2)Study completedNCT04188847
What this trial is testing

First-line Chemotherapy for Recurrent Cervical Cancer

Who this might be right for
Recurrent Cervical CarcinomaPersistent Advanced Cervical CarcinomaChemotherapy+3 more
Lei Li 37
Early research (Phase 1)Ended earlyNCT00322920
What this trial is testing

Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer

Who this might be right for
Cervix Cancer
University of Alabama at Birmingham 30
Testing effectiveness (Phase 2)UnknownNCT00826891
What this trial is testing

Study of Cisplatin in Cervical Cancer Stage IVB

Who this might be right for
Cervical Cancer
Chinese Anti-Cancer Association 40
Testing effectiveness (Phase 2)Study completedNCT00691301
What this trial is testing

Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Who this might be right for
Cervical Cancer
Gynecologic Oncology Group 55
Testing effectiveness (Phase 2)UnknownNCT04974944
What this trial is testing

First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer

Who this might be right for
Stage IVB Cervical CancerRecurrent Cervical CancerPersistent Cervical Cancer
Sun Yat-sen University 172
Load More Results
180